The invention relates to crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-.beta.-L-ribofuranosyl-1Hbenzimidazole, pharmaceutical compositions comprising the same, processes for preparing the same, and their use in medical therapy.

 
Web www.patentalert.com

< AAV vector compositions and methods for enhanced expression of immunoglobulins using the same

< Poplar transcription factors

> Method for the production of polyunsaturated fatty acids

> Biomarkers for toxic algae
~ 00606